In 2021, Kenya reported a total of 77,854 drug-sensitive Tuberculosis (DSTB) cases, representing a 6.7% increase compared to 2020 when the Country notified 72,943 DSTB cases. The incidence of TB in the country was estimated at 140,000 in 2021, indicating that at least 44% of incident TB cases were either missed or not notified in the year, indicating gaps in case notification. Among the top 10 counties with the highest number of DSTB cases in 2021 were Nairobi, Meru, Kiambu, Mombasa, Siaya, Nakuru, Turkana, Kitui, Homa Bay, and Machakos. Meru County specifically has been experiencing recurrent outbreaks, contributing the highest number of DS-TB cases in 2022.

Commodity availability and accessibility are crucial for providing TB services and sustaining the healthcare system. The National Strategic Plan for Tuberculosis, Leprosy, and Lung Health Program 2019 – 2023 outlines indicators for supply chain management of TB commodities to ensure their availability at all levels of the healthcare system. The Division of National Leprosy, Tuberculosis, and Lung Disease Program (DNLTD-P) has set targets for reporting rates, data quality, order fill rate, procurement turnaround time, pharmacovigilance reporting, surveillance, distribution, stock out rates, and expiry rates.